New patent expiration for Janssen Prods drug EDURANT – DrugPatentWatch
Annual Drug Patent Expiration for EDURANT
Edurant is a drug marketed by Janssen Prods and included in one NDA. It is available from a single supplier. There are four patents protecting this drug.
Price trends for EDURANT.
Drug patent litigation for EDURANT.
This drug has one hundred and eighty-six patent family members in forty-two countries.
The generic ingredient in EDURANT is rilpivirine hydrochloride. One registered supplier for this compound. Additional details are available on the rilpivirine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published on expiry of a new patent for the drug Janssen Prods EDURANT
